Sepsis is a multisystem disease characterized by dysregulation of the host immune
response to infection. Immune response kinetics play a crucial role in the pathogenesis and …

Evaluation of: Mei SH, Haitsma JJ, Dos Santos CC et al. Mesenchymal stem cells reduce
inflammation while enhancing bacterial clearance and improving survival in sepsis. Am. J …

Sepsis is a clinical syndrome caused by a deregulated host response to an infection. Sepsis
is the most frequent cause of death in hospitalized patients. Although knowledge of the …

Sepsis is a common clinical critical disease with high mortality. The excessive release of
cytokines from macrophages is the main cause of out-of-control immune response in sepsis …

Sepsis, newly defined as a life‐threatening organ dysfunction caused by a dysregulated
host response to infection, is the most common cause of death in ICUs and one of the …

Sepsis is a life-threatening disorder that is caused by a dysregulated inflammatory response
during an infection. The disease mostly affects pregnant women, newborns, and patients in …

Mesenchymal stem cells (MSCs) have been widely used in preclinical and clinical trials for
various diseases and have shown great potential in the treatment of sepsis and coronavirus …

The treatment of sepsis and septic shock remains a major public health issue due to the
associated morbidity and mortality. Despite an improvement in the understanding of the …

Background Sepsis is a severe medical condition that ranks among the top 10 causes of
death worldwide and which has permanently high incidence rates. Mesenchymal stem cells …

It is increasingly recognized that immunomodulation represents an important mechanism
underlying the benefits of many stem cell therapies, rather than the classical paradigm of …